
|Articles|May 12, 2006
Medtronic: For your approval
This is a sample of how your ads will appear around selected BPHcontent. Your ads will be the exclusive content on BPH articles andwill rotate with the other sponsors on General News items.
Advertisement
This is a sample of how your ads will appear around selected BPHcontent. Your ads will be the exclusive content on BPH articles andwill rotate with the other sponsors on General News items.
If you can, please provide up to 150 words to include about your company.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Published data show DFS benefit with aglatimagene besadenovec in localized prostate cancer
2
Study suggests potential diuretic effect with nadofaragene firadenovec
3
The UroOnc Minute: MDT for Oligometastatic Prostate Cancer, with Chad Tang, MD
4
Nicole L. Miller, MD, FACS, on assessing patients after BPH treatment failure
5











